Abstract
Abstract: We successfully treated esophageal varices by endoscopic variceal ligation (EVL) in a 50‐year‐old female patient with common variable immunodeficiency and liver cirrhosis secondary to hepatitis B. Under the existing disadvantageous conditions including the immunocompromised status, hyperal‐lergic reactions to several drugs, chronic pulmonary infection, and impaired hepatic function, we considered EVL to be of greater potential benefit than endoscopic injection sclerotherapy (EIS). This case highlights the possible merits of EVL over EIS, even in the presence of various restrictions, such as the immunocompromised condition of our patient.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
